Canadian Journal of Infectious Diseases and Medical Microbiology

Canadian Journal of Infectious Diseases and Medical Microbiology / 2015 / Article

Case Report | Open Access

Volume 26 |Article ID 531675 | https://doi.org/10.1155/2015/531675

Eleonora Vaisben, Ronen Brand, Anas Kadakh, Faris Nassar, "The Role of Empirical Albendazole Treatment in Idiopathic Hypereosinophilia - A Case Series", Canadian Journal of Infectious Diseases and Medical Microbiology, vol. 26, Article ID 531675, 2 pages, 2015. https://doi.org/10.1155/2015/531675

The Role of Empirical Albendazole Treatment in Idiopathic Hypereosinophilia - A Case Series

Abstract

Hypereosinophilia is usually defined as a blood eosinophil count >1500/μL. A broad variety of conditions are associated with hypereosinophilia. The present report describes three cases of hypereosinophilia, in which a thorough history, physical examination, laboratory and imaging investigations were unable to detect any abnormalities. Albendazole was empirically administered in all three cases, with complete normalization of eosinophil counts thereafter. Empirical treatment with albendazole for patients presenting with hypereosinophilia should be strongly considered.

Copyright © 2015 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Order printed copiesOrder
Views360
Downloads367
Citations

Related articles